Skip to main content
. Author manuscript; available in PMC: 2010 May 1.
Published in final edited form as: Pharmacogenomics. 2009 Jul;10(7):1177–1186. doi: 10.2217/PGS.09.41

Table 2.

Ten most significant allelic combinations differing in carriage between responders and nonresponders, their carriage rates among responders and nonresponders and the exact Fisher’s and permutation test p-values.

SNP1 SNP2 SNP3 SNP4 Carriage in Fisher’s
p-value
Odds ratio
(95% CI)
Permutation
p-value
R (%) NR (%)
JAK2 rs1887429*T IL10RB rs2834167*G GBP1 rs12089335*T PIAS1 rs10162905*A 4.8 20.7 0.00019 0.2 (0.1–0.5) 0.0008
JAK2 rs1887429*T IL10RB rs2834167*G GBP1 rs10493822*G 6.3 21.1 0.0008 0.2 (0.1–0.6) 0.0018
JAK2 rs1887429*T IL10RB rs2834167*G GBP1 rs12089335*T 6.2 20.7 0.0009 0.3 (0.1–0.6) 0.0019
JAK2 rs1887429*G IL10 rs1800872*A CASP3 rs2019978*G 13.9 1.1 0.0004 14.3 (1.9–109.1) 0.0012
JAK1 rs310249*G PNPT1 rs782584*C TYK2 rs2304256*C 5.3 20.7 0.0007 0.2 (0.1–0.5) 0.0017
JAK1 rs310249*G PNPT1 rs782584*C LEP rs7799039*G 5.3 20.7 0.0007 0.2 (0.1–0.5) 0.0017
JAK1 rs310249*G PNPT1 rs782584*C CASP7 rs12415607*C 6.2 22.0 0.0008 0.2 (0.1–0.6) 0.0018
JAK1 rs310249*G PNPT1 rs782584*C PRKR rs2270414*T 3.8 17.1 0.0013 0.2 (0.1-.06) 0.0023
JAK1 rs310249*G IFNAR2 rs8127890*A LEP rs7799039*A 1.5 12.5 0.0009 0.1 (0.02–00.5) 0.0019
TYK2 rs280501*C DUSP1 rs881150*T PRKCA rs3764402*A 90.7 73.1 0.0012 3.6 (1.6–8.0) 0.0023

NR: Nonresponder; R: Responder